Medscape engagement report
@Medscape - 291K followers on X
Measured over 40 original posts from a 30-day window, last computed on October 22, 2026.
Engagement
A typical post picks up 5 interactions against 291K followers, an engagement rate of 0.002%. Measured over 40 original posts, its engagement rate beats 8% of 20,444 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 1.2K times each, and 0.402% of those impressions turn into an interaction. That is about 0.427% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 1.3 post a day over the last 30 days, though only 10% of days saw any activity at all. Most posts go out around 16:00 UTC, and Wednesday is the busiest day of the week. Of the 40 posts sampled, 73% carry an image or video and 95% link out. The account's strongest tracked post pulled 346 interactions, about 69x its own typical post. Recurring topics include #cme, #aafpfmx, #meded.
Measured over 40 original posts from a 30-day window, last computed on October 22, 2026. Recurring tags: #cme, #aafpfmx, #meded.
Compared with accounts its own size
Medscape's engagement rate beats 8% of the tracked X accounts closest to it in follower count (20,444 accounts, accounts of similar size (decile 9 of 10)). A percentile is spread evenly by construction, so 50 really is the middle of that group and 90 really is its top tenth.
On engagement per impression rather than per follower it beats 22% of the same group. When those two numbers disagree, the gap is about how far its posts travel rather than how people react to them.
Where this sits in the catalog
At 0.002%, Medscape sits below the 10th percentile of the 205,374 accounts in this comparison. That places it in the bottom 25% band, which runs below 0.024%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.024% |
| 50th percentile | 0.143% |
| 75th percentile | 0.678% |
| 90th percentile | 2.55% |
| 99th percentile | 82.4% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 16:00 UTC, and Wednesday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 73% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 95% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | +15% | +14% to +16% | 32K |
- 73% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 95% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts, so a large share of this account's output sits in the weakest bucket we measure.
- Its average post runs 332 characters, which falls in the over 280 characters band. Across the catalog, posts over 280 characters run 15% above the same accounts' other posts.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Sep 3, 202669x their median
The increasing number of younger patients with shingles has prompted debate about expanding free vaccination eligibility. https://t.co/cSlashADVb https://t.co/Ke64QD7DSs
- Sep 19, 202635x their median
The COVID pandemic was officially declared over more than 3 years ago. Today, 6 years after the identification of SARS-CoV-2 — the virus that brought much of the world to a near standstill — fear of infection seems to have all but disappeared. Although various aspects of the pandemic continue to be debated, COVID has largely faded from public consciousness as a potentially severe illness. On the one hand, this is because nearly all subvariants currently circulating are descendants of the comparatively less pathogenic Omicron variant, and acute cases are therefore generally milder than those seen at the start of the pandemic. On the other hand, repeated exposure to the antigen has led to a high level of baseline immunity in the population as a whole. An assessment of the COVID situation in 2026 highlights two medical priorities: improving the treatment of COVID sequelae and evaluating the effectiveness of existing therapies for the prevention of long COVID and post-COVID syndrome (PCS). https://t.co/38NLUN7aBi
- Sep 19, 202618x their median
Two additional cases of curing HIV through otherwise indicated stem cell transplant were reported at AIDS 2026 this year, bringing the total number of cured HIV cases reported to date to 13. One of these cases, the “Essen patient” occurred despite complex virologic conditions and being the first with mixed HIV-1 tropism, reported Carina Elsner, of the Institute for Virology at University Medicine Essen in Essen, Germany. “This is providing new insights into the role of viral tropism in HIV cure,” Elsner told attendees. “The key question is: Is the presence of this CCR5-delta32 mutation really the key to achieving an HIV long-term remission,” or can it be achieved without that? https://t.co/tjH3zo7gRF
- Sep 4, 202618x their median
Updated migraine prevention guidance incorporates calcitonin gene-related peptide (CGRP)-targeted therapies and places greater emphasis on individualized treatment selection based on patient priorities. Developed by the American Academy of Neurology (AAN) and American Headache Society, the updated guideline replaces recommendations issued in 2012 and covers pharmacologic prevention of both episodic and chronic migraine in adults. https://t.co/y8FddleB6B
- Sep 5, 202615x their median
GLP-1 receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated. But these drugs have also shown a surprising ability to improve cardiovascular health — and not just because losing weight benefits the heart. “These effects were not predicted,” said Michael Nauck, MD, head of clinical research at the Diabetes Division of St. Josef Hospital at Ruhr University Bochum in Bochum, Germany. “There were no animal studies or even basic physiology suggesting they would be helpful for the cardiovascular system.” In 2008, the FDA ordered a series of cardiovascular outcomes trials after two studies suggested lowering blood sugar could be dangerous for the heart in patients with type 2 diabetes. All of the drugs tested were shown to be safe, and several showed significant reductions in composite major adverse cardiovascular event endpoints, which usually included cardiovascular death, nonfatal heart attack, and nonfatal ischemic stroke, compared with placebo. Read more by tapping the link: https://t.co/kunVFBEOTZ
- Sep 5, 202612x their median
Oral vitamin B3 (nicotinamide) at 500 mg twice daily for 14 days improved nailfold videocapillaroscopy (NVC) patterns in around 45% of participants with primary or scleroderma-related Raynaud phenomenon (RP), with increased normal capillaries and reduced abnormal features. Participants with primary RP experienced improvements in RP-related quality of life. https://t.co/HZK9i5mhfD
- Sep 18, 202611x their median
Patients with rheumatic diseases who used GLP-1 receptor agonists experienced sustained weight loss and improved glycaemic and lipid measures, and inflammatory markers also declined among those with chronic inflammatory arthritis. Researchers conducted a retrospective, real-world cohort study at a Spanish rheumatology centre between October 2024 and 2025 to evaluate the metabolic effectiveness, inflammatory signal, and safety of GLP-1 RAs in rheumatology outpatients. Read about the research at the link: https://t.co/kHGERVw9tn
- Oct 22, 202611x their median
Every doctor can get bogged down with an endless daily to-do list consisting of everything from pre-authorizations and prescription refill requests to handling in-box messages from the patient portal, and endless electronic health record tasks. These critical (but often invisible) tasks done “behind the scenes” usually take place before patients arrive in the early hours of the morning or at home late into the night — and are drivers of both burnout and exhaustion, with much of this non-patient work spilling into weekend and weeknight hours. https://t.co/yFXQUz8CHl
- Sep 20, 202611x their median
Even as GLP-1 drugs transform obesity care and reduce cardiovascular risk, statins retain an essential role in lowering cholesterol and preventing cardiovascular risk events. https://t.co/QUyKlT6a2L https://t.co/TfLE33J4ix
- Sep 17, 202610x their median
Whether pharmacologic treatment of obesity with GLP-1 receptor agonists (RAs) should continue indefinitely once initiated was debated at the 37th Brazilian Congress of Endocrinology and Metabolism (CBEM 2026) held in Rio de Janeiro, Brazil, from August 26 to 29, 2026. Differing views highlighted an ongoing clinical question in obesity management: whether GLP-1 RAs should generally be considered long-term therapy or whether treatment can be reduced or discontinued in selected patients who maintain weight loss without medication. Tap the link to read more: https://t.co/2ilFYW8dxw
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 5 interactions against 291K followers, an engagement rate of 0.002%. Measured over 40 original posts, its engagement rate beats 8% of 20,444 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 1.2K times each, and 0.402% of those impressions turn into an interaction. That is about 0.427% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 1.3 post a day over the last 30 days, though only 10% of days saw any activity at all. Most posts go out around 16:00 UTC, and Wednesday is the busiest day of the week. Of the 40 posts sampled, 73% carry an image or video and 95% link out. The account's strongest tracked post pulled 346 interactions, about 69x its own typical post. Recurring topics include #cme, #aafpfmx, #meded.
- What is Medscape's engagement rate on X?
- Medscape (@Medscape) has an engagement rate of 0.002%, based on the median interactions across 40 original posts from the last 30 days against 291,153 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.002%, Medscape sits below the 10th percentile of the 205,374 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @Medscape have real engagement?
- Its engagement rate beats 8% of the tracked X accounts closest to it in follower count (20,444 accounts), which puts it in the bottom 10% for its size group. Ranking inside a size band matters because engagement rate falls as accounts grow, so a raw rate would mostly re-measure the follower count. It is a starting point for a look at follower quality, not a verdict on it.
- When does @Medscape post?
- Most posts go out around 16:00 UTC, and Wednesday is its busiest day, at roughly 1.33 posts per day across the measured window.